Tuesday, March 19, 2013

• New Data on Biogen/Elan's TysabriZacks (Tue, Mar 19)
• Biogen’s MS Pill Gains 8 More Years of Patent Protectionat Bloomberg (Tue, Mar 19)
• US Patent Office Grants Patent Claiming Dosing Regimen for TECFIDERA™ (Dimethyl Fumarate)Business Wire (Tue, Mar 19)
• Biogen receives patent until 2028 for MS drug Tecfideraat Reuters (Tue, Mar 19)
• Biogen Idec Inc Stock Buy Recommendation Reiterated (BIIB)at TheStreet (Tue, Mar 19)

Monday, March 18, 2013

• 4 Healthcare Stock Stories Not To Be Overlookedat Wall St. Cheat Sheet (Mon, Mar 18)
• ADDING MULTIMEDIA New TYSABRI Data Reaffirm Substantial Efficacy in Treatment of People with MS and Demonstrate Stability of Anti-JCV Antibody StatusBusiness Wire (Mon, Mar 18)
• Biogen, Elan announce results from several TYSABRI studiestheflyonthewall.com (Mon, Mar 18)

Friday, March 15, 2013

• Better Biotech Buy: Biogen vs. Celgeneat Motley Fool (Fri, Mar 15)
• 4 Key Drug Approvals Expected In The Next 30 Daysat Investor's Business Daily (Fri, Mar 15)

Thursday, March 14, 2013

• BIOGEN IDEC INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial ObligEDGAR Online (Thu, Mar 14)
• Zacks Bull and Bear of the Day Highlights: Cincinnati Financial, ArcelorMittal, Biogen, Sanofi and Osiris TherapeuticsZacks (Thu, Mar 14)

Wednesday, March 13, 2013

• Biogen Files Hemophilia B ApplicationZacks (Wed, Mar 13)
• 4 Healthcare Stock Stories for Wednesday Investment Wellnessat Wall St. Cheat Sheet (Wed, Mar 13)
• Biogen stock rides high on hopes for new MS drugat bizjournals.com (Wed, Mar 13)
• Sunesis Pharma posts smaller 4th-quarter lossAP (Wed, Mar 13)
• Jim Cramer: Buy Las Vegas Sands and These 2 Solid Stocks, Sell Diamond Foodsat Wall St. Cheat Sheet (Wed, Mar 13)
• Boeing May Announce New Order and 4 Stocks At 52-Week Highsat Wall St. Cheat Sheet (Wed, Mar 13)
• Cramer's Lightning Round - Stay Away From The Nuts At Diamond (3/12/13)at Seeking Alpha (Wed, Mar 13)
• 'Mad Money' Lightning Round: Buy, Buy, Buy Biogen Idecat TheStreet (Wed, Mar 13)

Tuesday, March 12, 2013

• Lightning Round: Biogen, Kansas City Southern & Moreat CNBC (Tue, Mar 12)
• Biogen Idec Stock Hits New 52-Week High (BIIB)at TheStreet (Tue, Mar 12)
• Biogen submits application for hemophilia A candidate to FDAat bizjournals.com (Tue, Mar 12)
• Analysts: Apple May Miss Guidance and 4 New Opinions Investors Must Know Nowat Wall St. Cheat Sheet (Tue, Mar 12)
• Biogen seeks approval of hemophilia A treatmentAP (Tue, Mar 12)

Add BIIB News to My Yahoo!